Insulin-producing pancreatic islet β cells (β-cells) are destroyed, severely depleted or functionally impaired in diabetes. Therefore, replacing functional β-cell mass would advance clinical diabetes management. We have previously demonstrated the importance of Cdk4 in regulating β-cell mass. Cdk4-deficient mice display β-cell hypoplasia and develop diabetes, whereas β-cell hyperplasia is observed in mice expressing an active Cdk4R24C kinase. While β-cell replication appears to be the primary mechanism responsible for β-cell mass increase, considerable evidence also supports a contribution from the pancreatic ductal epithelium in generation of new β-cells. Further, while it is believed that majority of β-cells are in a state of ‘dormancy’, it is unclear if and to what extent the quiescent cells can be coaxed to participate in the β-cell regenerative response. Here, we address these queries using a model of partial pancreatectomy (PX) in Cdk4 mutant mice. To investigate the kinetics of the regeneration process precisely, we performed DNA analog-based lineage-tracing studies followed by mathematical modeling. Within a week after PX, we observed considerable proliferation of islet β-cells and ductal epithelial cells. Interestingly, the mathematical model showed that recruitment of quiescent cells into the active cell cycle promotes β-cell mass reconstitution in the Cdk4R24C pancreas. Moreover, within 24–48 hours post-PX, ductal epithelial cells expressing the transcription factor Pdx-1 dramatically increased. We also detected insulin-positive cells in the ductal epithelium along with a significant increase of islet-like cell clusters in the Cdk4R24C pancreas. We conclude that Cdk4 not only promotes β-cell replication, but also facilitates the activation of β-cell progenitors in the ductal epithelium. In addition, we show that Cdk4 controls β-cell mass by recruiting quiescent cells to enter the cell cycle. Comparing the contribution of cell proliferation and islet-like clusters to the total increase in insulin-positive cells suggests a hitherto uncharacterized large non-proliferative contribution.
Citation: Lee J-H, Jo J, Hardikar AA, Periwal V, Rane SG (2010) Cdk4 Regulates Recruitment of Quiescent β-Cells and Ductal Epithelial Progenitors to Reconstitute β-Cell Mass. PLoS ONE 5(1): e8653. doi:10.1371/journal.pone.0008653
Editor: Kathrin Maedler, University of Bremen, Germany
Received: July 15, 2009; Accepted: December 10, 2009; Published: January 13, 2010
This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Funding: This work was supported by funds from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health intramural program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Pancreatic β-cells are uniquely endowed with the ability to synthesize and secrete insulin – a hormone essential for glucose control . Autoimmune destruction of β-cells results in Type 1 diabetes. Type 2 diabetes is characterized by significantly reduced β-cell mass that combines with β-cell dysfunction resulting in a deficit in β-cell compensation mechanisms in the face of glucose intolerance and insulin resistance , , . Therefore, restoration of β-cell mass is of major clinical significance in both forms of diabetes. It is known that adult β-cells exhibit limited proliferation capacity that is dependent on genetic background , , . Furthermore, β-cells turn over slowly and their proliferation potential decreases with age , . Several potential mechanisms for regulating β-cell mass have been supported by ongoing research . Pancreatic stem cells, embryonic or arising from diverse locations such as pancreatic ducts, islets and bone marrow, have been proposed as sources of insulin-producing β-cells , , , , , . Other reported sources are trans-differentiation of pancreatic acinar cells, liver cells, differentiation of intra-islet precursors or splenocytes, and epithelial-mesenchymal transition , , , , , , , although recent studies have challenged some of these findings , , . Furthermore, induced genetic reprogramming of adult exocrine cells to functional β-cells has been recently reported . Among these possible sources, elegant lineage tracing analyses and other approaches convincingly demonstrate that β-cell self-duplication is a dominant source of adult β-cells , , . A recent report shows the existence of facultative stem cells in the pancreatic ductal epithelium and their recruitment in response to an acute pancreatic injury . These results suggest that the two major mechanisms that increase β-cell mass are (i) duplication of pre-existing β-cells and (ii) generation of β-cells via recruitment of facultative stem/progenitor cells within the pancreatic ductal epithelium.
The cell cycle machinery receives signals transduced by various growth factor pathways and controls cellular quiescence, proliferation, differentiation, senescence, and apoptosis , . The retinoblastoma protein (RB) negatively regulates the passage of cells from G1 to S phase primarily by sequestering E2F transcription factors and chromatin modifiers critical for the G1/S transition. Cyclin-dependent kinases (Cdk's) promote S-phase progression and mitosis by phosphorylating and, thereby, inactivating RB. The activity of Cdk's is negatively regulated by the Ink4 and Cip/Kip families of cyclin-dependent kinase inhibitors (Cki's). Using mice with genetically modified Cdk4 loci, we have previously shown that Cdk4 regulates β-cell mass , , , . Cdk4−/− mice exhibit β-cell hypoplasia and develop diabetes, whereas Cdk4R24C/R24C mice (Cdk4R/R mice), inheriting the p16Ink4a-insensitive Cdk4R24C kinase, exhibit β-cell hyperplasia. Several recent studies have underscored the important roles of other cell cycle regulators in β-cell biology , , , , , , .
While it is known that Cdk4 influences the size of the post-natal β-cell compartment, it is unknown whether this kinase regulates β-cell mass in response to regenerative stimuli and physiological demand. Cdk4R24C promotes autoreactivity in the immune system when backcrossed onto the non-obese diabetic (NOD) background but it also protects pancreatic β-cell mass from autoimmune destruction when introduced into the NOD/SCID mouse . While β-cell replication appears to be the primary mechanism responsible for β-cell mass increase , , , considerable evidence also supports a contribution from the pancreatic ductal epithelium in generation of new β-cells , , , , , . However, the molecular regulators that govern the processes of β-cell replication or progenitor cell activation are not known and it is unclear whether Cdk4 regulates β-cell mass via either of these mechanisms. Further, while it is believed that the majority of β-cells are in a state of ‘dormancy’, it is not clear if and to what extent these quiescent cells can be coaxed to participate in the β-cell regenerative response. We address these issues in the present study. Our results demonstrate that Cdk4 enhances β-cell replication within islets and activates progenitors within the pancreatic ductal epithelium in response to partial pancreatectomy. Further, mathematical modeling of data derived upon DNA analog-based lineage-tracing suggests that Cdk4 recruits quiescent islet β-cells and ductal β-cell progenitors into a proliferation cycle. These results underscore the critical role played by Cdk4 in the regulation of β-cell mass.
Efficient β-Cell Regeneration in Cdk4R/R Mice in Response to Pancreatectomy
Considering the critical role of Cdk4 in regulating post-natal β-cell mass , , we set out to determine its importance in controlling β-cell replication within islets and in modulating the activity of presumptive progenitor cells in the pancreatic ductal epithelium. The processes of islet β-cell replication and ductal progenitor cell activation can be simultaneously analyzed in a 60% partial pancreatectomy (PX) model . We performed 60% PX in 8-week-old Cdk4-wild type (Cdk4WT) and Cdk4R/R mice. Sham-operated mice from both genotypes served as controls. Mice were observed for a period of 28 days post-PX. No significant changes in body weights were observed in either the Cdk4WT or Cdk4R/R mice post-PX (Fig. 1A), and, consistent with prior reports , , no significant hyperglycemia was observed in either genotype (Fig. 1B), thus excluding hyperglycemia as a major factor underlying the regenerative response. Comparable β-cell mass was observed in Cdk4WT and Cdk4R/R mice immediately after PX (day 0), whereas, 14 days after PX, a significant increase in β-cell mass was observed in the Cdk4R/R mice, compared with Cdk4WT mice (Fig. 1C). The β-cell mass increase observed in Cdk4WT mice is consistent with that reported by Peshavaria et al., using a similar 60% PX model . No further increase in β-cell mass was seen at day 28 post-PX in mice of either genotype. These observations indicate that Cdk4R24C promotes rapid β-cell regeneration in response to PX.
(A) Body weight change and (B) fed-state blood glucose levels were measured before (day 0) and on indicated days after PX on Cdk4WT mice (open squares) and Cdk4R/R mice (closed squares). (C) β-cell mass is increased after PX in both groups. Significant increase of β-cell mass was observed in Cdk4R/R mice (closed bars) compared with Cdk4WT mice (open bars) by 14 days after PX. Data are shown as means and error bars represent S.E. *p<0.05 vs Cdk4WT mice.
Increased Islet β-Cell Replication in Cdk4R/R Mice following Pancreatectomy
We quantified β-cell proliferation in the Cdk4WT and Cdk4R/R mice post-PX by staining for both bromodeoxyuridine (BrdU) and insulin (Ins) using standard immunohistochemistry (Fig. 2A). No significant difference in β-cell proliferation, as measured by counting BrdU+:Ins+ cells, was observed in Cdk4WT and Cdk4R/R pancreas immediately after PX (day 0) or 1 day after PX (Fig. 2A). A more than two-fold increase in β-cell proliferation was seen in Cdk4WT and Cdk4R/R mice by day 2 post-PX. No further increase in β-cell replication was seen in the Cdk4WT islets after day 2 post-PX. In contrast, a significant increase in β-cell proliferation was seen at day 14 post-PX in the Cdk4R/R islets. These observations demonstrate enhanced islet β-cell proliferation post-PX in Cdk4R/R mice.
(A) Islet β-cell proliferation was significantly increased in Cdk4R/R mice (closed bars) compared with Cdk4WT mice (open bars) by 14 days after PX. The picture on the left shows BrdU+ (brown) and insulin+ (blue) β-cell (red arrow) and BrdU negative β-cell (yellow arrow). (B) Proliferation of pancreatic ductal epithelial cells was significantly increased within 2 days post-PX in Cdk4R/R mice (closed bars) compared with Cdk4WT mice (open bars). Arrow heads in picture on left indicate BrdU+ ductal cells. Data are shown as means and error bars represent S.E. *p<0.05, **p<0.01, and ***p<0.001 vs Cdk4WT mice. Note that BrdU-labeled cells result from a 16-hr-labeling period.
Enhanced Pancreatic Ductal Epithelial Cell Proliferation in Cdk4R/R Mice
The pancreatic ductal epithelium has been proposed to serve as a reservoir of potential facultative progenitor cells capable of differentiating into β-cells . Indeed, the recruitment of such progenitors is observed in response to pancreatic injury . We looked for evidence suggestive of ductal progenitor cell activation in Cdk4WT and Cdk4R/R mouse pancreas post-PX. First, we estimated pancreatic ductal epithelial cell proliferation by BrdU staining combined with staining for cytokeratin (CK) as a ductal epithelium marker. We observed very low levels of ductal cell proliferation in Cdk4WT pancreas prior to and at any time after PX (Fig. 2B). On the other hand, ductal cell proliferation was significantly increased in Cdk4R/R pancreas before PX (day 0) and at day 1 post-PX (Fig. 2B). Interestingly, ductal cell proliferation increased more than 10-fold in the Cdk4R/R pancreas by day 2 post-PX. The significant elevation of ductal epithelial cell proliferation was maintained in the Cdk4R/R pancreas until day 14 post-PX, although the absolute cell proliferation was less than that seen at day 2 post-PX. These data demonstrate robust ductal cell proliferation in the Cdk4R/R pancreas as early as 2 days after PX.
Kinetics of Proliferation in Islet β-Cells and Ductal Epithelial Cells after Pancreatectomy
To observe cell-division kinetics in detail, we adapted a DNA analog-based lineage-tracing technique using dual thymidine analogs, 5-chloro-2-deoxyuridine (CldU) and 5-iodo-2-deoxyuridine (IdU) . Each thymidine analog detects a distinct round of cell division; thus, it allows estimation of more than one round of cell division in vivo when the two analogs are sequentially provided in drinking water over defined time-periods. As schematically depicted in Fig. 3A, mice were provided CldU-containing water during the first pulse period, IdU-containing water during the second pulse period, and water without any DNA analogs during a chase period. We used three protocols each with different administration periods (Fig. 3B). The first protocol, 2-2-4 (first pulse period-second pulse period-measure time point), was designed to identify cell division kinetics within the first 4 days post-PX where, in the BrdU-labeling experiment, we had observed limited β-cell replication (Fig. 2A) but significantly enhanced ductal cell proliferation (Fig. 2B). The second protocol, 2-2-14, incorporated a 10-day chase period subsequent to the 4-day pulse period to monitor the re-division of cells that proliferated in the prior pulse period. The third protocol, 7-7-14, was designed to identify cells undergoing slow division over the entire 14 days post-PX. Immunohistochemistry with insulin and CK identified β-cells and ductal epithelium cells, respectively, and showed CldU+ or IdU+ single positive, or CldU+:IdU+ double positive cells after the labeling experiment (Figs. S1 and S2). We have summarized the labeling ratios for the three protocols in Table S1. The ratios represent accumulated cell proliferation during each labeling period.
(A) Schematic description of cell proliferation under the double-labeling experiment. Two initial populations of quiescent (black) and active (white) cells are subjected to two pulse (CldU and IdU) and one chase periods. The numbers of once- and twice-proliferated cells are represented by and (during the CldU period); and (during the IdU period); and and (during the chase period). The number of purple twice-proliferated (once in CldU and once in IdU) cells are denoted with . Note that some labeled cells divide during the chase period and decrease their labeling intensity. They are described with slashed green and red cells in the chase period. (B) Three protocols of the double-labeling experiment with two pulse periods and following chase period.
Mechanism of Enhanced Cell Proliferation in Cdk4R/R Mice
The double-labeling experiment allows us to examine the dynamics of cell proliferation. A given labeling ratio of cell proliferation may arise from two distinct scenarios: either all cells proliferate at a certain rate or subsets of cells proliferate at a higher rate. If double-labeled cells are frequently observed, the second scenario is more probable. In this study, however, we observed rare double-labeled (CldU+:IdU+) cells within a short labeling period (14 days) regardless of genotype (Table S1). A low rate of cell division can lead to the observation of these rare double-labeled cells. However, if cells that have proliferated once require a refractory period before they undergo additional rounds of proliferation , despite the existence of limited highly-proliferating cells, the numbers of double-labeled cells may still remain low. We addressed these possibilities by introducing a mathematical model that allows study of the aforementioned events in quantitative detail to elucidate the relative likelihoods of these distinct scenarios (see the Materials and Methods section). In the model, we considered two cell populations of active and quiescent cells; only active cells can proliferate. In addition, we neglected multiple proliferation events of the active cells because such events are sufficiently rare. Then, we fitted the data to the models with different initial number ratios of quiescent to active cells, . For example, means there are no quiescent cells, i.e., every cell exhibits an equal proliferation potential. Using the cell proliferation information from the BrdU and CldU/IdU labeling experiments, the model predicted number changes of quiescent, active, and proliferated cells in islets and ducts of Cdk4WT and Cdk4R/R mice (Fig. 4); the comparison between model prediction and experimental data was shown in Table 1. Furthermore, Figure 4 showed the proliferation rate of active cells and the proportion of proliferated cells per day. Two possibilities for enhanced cell proliferation in Cdk4R/R mice are accelerated proliferation of active cells and recruitment of quiescent cells into active cell population. Our results demonstrated no difference in cell proliferation rate of active cell populations; average proliferation rates of active cells during 14 days after pancreatectomy are 16.1±12.3 vs. 16.4±12.2 (% per day) for β-cells in Cdk4WT and Cdk4R/R mice; and 15.3±10.8 vs. 7.5±0.4 (% per day) for ductal cells in Cdk4WT and Cdk4R/R mice. On the other hand, the ratio of quiescent to active cell populations decreased in both β-cells and ductal cells in Cdk4R/R mice: 48±27 vs. 18±20 for β-cells in Cdk4WT and Cdk4R/R mice; and 56±26 vs. 0±0 (0.04±0.04) for ductal cells in Cdk4WT and Cdk4R/R mice. Furthermore, model comparison, using the Bayesian model probability for the given data, , showed that a smaller quiescent cell population (small ) is a more likely explanation of the labeling data of Cdk4R/R mice, compared with the labeling data of Cdk4WT mice (Fig. S3).
Changes of quiescent, active, and proliferated cell numbers (,, and ) normalized by initial active cell number; proliferation rate of active cells; and ratio of proliferated cells among entire cell population are plotted.
Increased Pdx-1+ Cells in the Cdk4R/R Pancreatic Ductal Epithelium after Pancreatectomy
The pancreatic duodenal homeobox 1 (Pdx-1/Idx-1/Ipf-1/Stf-1) transcription factor is an essential regulator of early pancreatic development , . Pdx-1 is expressed in the mouse primitive gut as early as the 13 somite stage (E8.5), about a day before endocrine gene expression and 1.5 days before the first morphologic evidence of pancreas organogenesis. Subsequently, Pdx-1 is transiently present in the fetal duodenum and in pancreatic exocrine, endocrine and ductal cells, although Pdx-1 expression is suppressed in late fetal development (E15.5). In adult pancreas, Pdx-1 is localized mainly within β-cells where it functions as a transcriptional regulator of β-cell specific genes including insulin, glucokinase and glut2. Interestingly, factors that determine organogenesis, such as Pdx-1, frequently get activated during the regeneration processes and recapitulate stages traversed during embryonic development. Indeed, presence of Pdx-1-positive (Pdx-1+) cells in the pancreatic ductal epithelium has been demonstrated in rodent models following PX , , . Therefore, we performed immunofluorescence assays to detect Pdx-1 expression in the pancreatic sections from Cdk4WT and Cdk4R/R mice before and after PX. The presence of ductal cells was verified by expression of CK and the number of Pdx-1 and CK double positive cells within the pancreatic ductal epithelium was determined (Fig. 5A). Prior to PX, Pdx-1+ cells were rare or non-existent in the control Cdk4WT pancreatic ductal epithelium (Fig. 5B). In contrast, higher numbers of ductal Pdx-1+:CK+ cells were observed in the Cdk4R/R pancreas before PX. The percentage of Pdx-1+:CK+ ductal cells increased at day 1 post-PX in the Cdk4WT pancreas and reached ~3% at day 14 post-PX (Fig. 5B). This illustrates the capacity of normal pancreas to promote activation of Pdx-1+ cells in response to PX. Significantly, the activation was greater in the Cdk4R/R pancreatic ductal epithelium, where we observed a 5-fold increase in the ratio of Pdx-1+:CK+ cells within 1 day after PX, and a further significant increase in the ratio at day 2 post-PX. However, at day 14 post-PX, the ratio was reduced to a level comparable to the ratio observed in the Cdk4WT pancreas at day 14 post-PX. These observations demonstrate a significantly-increased pool of Pdx-1+:CK+ ductal epithelial cells in the regenerating Cdk4R/R pancreas as an immediate early response to PX.
(A) A representative picture of Pdx-1 expression observed within the cytokeratin (CK)-positive pancreatic ductal epithelium from Cdk4R/R mice. Arrows show Pdx-1+:CK+ cells. Blue color identifies DAPI-stained nuclei. (B) Percentage of Pdx-1+ ductal epithelial cells was significantly increased by 2 days post-PX in Cdk4R/R mice (closed bars) compared with Cdk4WT mice (open bars). Data are shown as means from four mice of each genotype per group and error bars represent S.E. **p<0.01, and ***p<0.001 vs Cdk4WT mice.
Increased Islet-Like Cell Clusters in Cdk4R/R Pancreas after Pancreatectomy
To determine whether insulin is expressed in the ductal epithelium of the Cdk4R/R pancreas, we performed immunofluorescence assays using insulin and CK antibodies to detect Ins and CK double positive cells. Ins+:CK+ cells were either rare or undetectable in the ductal epithelium of the Cdk4WT pancreas either before or after PX. In contrast, Ins+:CK+ cells were frequently seen in the ductal epithelium of the Cdk4R/R pancreas post-PX (data not shown). In response to regeneration, co-incident with the appearance of the rare Ins+ ductal epithelial cells, small islet-like cell clusters (ICCs) have been reported to originate in the vicinity of the ductal epithelium . Further, ICCs are considered to represent newly-differentiated β-cells that originate from progenitors localized within the ductal epithelium. We next counted the number of ICCs (ie. those clusters with fewer than 5 β-cells) near the pancreatic ducts before and after PX in our experimental mice (Fig. 6A). Prior to PX, we observed a modest yet significant increase in the number of duct-associated ICCs in the Cdk4R/R pancreas (Fig. 6B). No increase in the number of ICCs was observed in the Cdk4WT pancreas by day 2 post-PX, although a significant increase in the number of ICCs was seen at day 14 post-PX. Interestingly, we detected a significant ~3-fold increase in the number of ICCs in Cdk4R/R pancreas as early as day 2 post-PX (Fig. 6B). Moreover, the number of ICCs in the Cdk4R/R pancreas continued to rise significantly and by day 14 post-PX were increased by ~5-fold compared with the number of ICCs prior to PX. Together, these observations demonstrate the ability of the Cdk4R/R pancreatic ductal epithelium to (i) proliferate extensively, (ii) express the putative pancreatic progenitor marker, Pdx-1, (iii) express insulin, a marker of mature differentiated β-cells, and (iv) promote the development of insulin-positive small ICCs.
(A) The number of ICCs that contain 5 or less insulin+ cells was counted. Left picture shows DAPI staining and the pancreatic duct (D) is identified by white stippled line. Right picture shows the mature islet (I) and an ICC (yellow arrow) identified upon immunofluorescence staining with insulin antibodies. (B) Number of ICCs was significantly increased before and after PX in Cdk4R/R mice (closed bars) compared with Cdk4WT mice (open bars). Values are the results obtained from four mice per group at each time point and expressed as mean number of ICCs per section. Error bars represent S.E. *p<0.05, **p<0.01, and ***p<0.001 vs Cdk4WT mice.
β-cells, like all other cells, are under the regulatory checks and balances enforced by changes in cell cycle progression . Proof of this concept was provided using mouse models wherein the locus that codes for Cdk4, one of the important gate-keepers of the mammalian cell cycle machinery, was targeted by genetic recombineering , . These studies illustrated that loss of Cdk4 results in β-cell hypoplasia and diabetes. In contrast, inheritance of a mutant Cdk4R24C kinase, that is refractory to cell cycle inhibition by p16Ink4a, resulted in β-cell hyperplasia , . Although these studies illustrated the unique role of Cdk4 in β-cell mass regulation, the mechanisms by which Cdk4 controls β-cell mass have remained unclear. Here, using a model of partial pancreatectomy, we showed that Cdk4 regulates post-natal β-cell mass by targeting two different cellular compartments: the pre-existing β-cells within islets and presumptive progenitors localized in the pancreatic ductal epithelium. Furthermore, we show that Cdk4 utilizes two distinct mechanisms to engineer β-cell mass re-constitution in response to pancreatectomy. First, the data is compatible with Cdk4 promotion of islet β-cell replication, a mechanism that is presumed to play a primary role in regulating β-cell mass. Second, Cdk4 catalyzes the recruitment of quiescent cells within the islets and the ductal epithelium to participate in the regenerative process. Interestingly, recruitment of quiescent cells within the ductal epithelium displays hallmarks of early pancreatic development . Therefore, pancreatectomy induces rapid proliferation of ductal epithelial cells and a coincident significant increase in cells that express Pdx-1, a transcription factor that is involved in the earliest stages of embryonic pancreas development. The rapid proliferation kinetics combined with the appearance of Pdx-1+ cells suggests involvement of activated progenitors in response to injury. Moreover, we observe increased insulin-positive cells in the ductal epithelium and a significant enhancement in the number of duct-associated small ICCs. Together, we illustrate that Cdk4 stimulates β-cell regeneration by promoting β-cell replication and inducing progenitor cell activation by recruitment of quiescent cells into the active cell cycle (Fig. 7).
(A) Like all cells, β-cells and pancreatic ductal epithelial cells also traverse the cell cycle. A significant fraction of these cells are in the G0 state referred to as quiescence. Our data suggest that Cdk4 promotes cell cycle re-entry of quiescent cells. In addition, Cdk4 enhances cell cycle progression via stimulating G1 to S-phase transition. The p16Ink4a-Cdk4 pathway shown is operational during recruitment of quiescent cells into the cell cycle and to promote the G1 to S-phase cycling of cells already in cycle. These events are suppressed by p16Ink4a and promoted by Cdk4 which inactivates RB thereby releasing E2F to drive S-phase progression. (B) Cdk4 appears to target the islets and the pancreatic ductal epithelium during a regenerative response to pancreatectomy and the proposed model outlines the events orchestrated by Cdk4. Islets are comprised of mature differentiated β-cells and a small fraction of these β-cells undergo proliferation in response to regeneration. Cdk4 promotes limited replication of pre-existing β-cells. In addition, we propose that majority of β-cells are quiescent. In response to pancreatectomy, Cdk4 recruits the quiescent cells into an active cell cycle, thereby increasing the pool of actively-dividing cells within the islet. Cdk4 appears to elicit a slightly different program in ducts in response to pancreatectomy. The duct is mainly comprised of cytokeratin-positive (CK+) epithelial cells, with rare proliferating cells, a limited number of cells that express the early pancreatic development marker, Pdx-1, and rare duct-associated ICCs. In response to pancreatectomy, the proliferation activity, Pdx-1 expression, and numbers of ICCs are increased by the cell cycle progression in addition to recruitment of quiescent ductal cells into the active cell cycle.
We estimated contributions of both the mechanisms - replication and recruitment from quiescence - to the overall increase in β-cell mass during 14 days after pancreatectomy (0.25±0.29 to 0.85±0.38 mg in Cdk4WT pancreas; and from 0.38±0.10 to 1.55±0.28 mg in Cdk4R/R pancreas). Estimated contributions by β-cell proliferation are 8% (~0.02 mg) and 34% (~0.13 mg) of the total increase of initial β-cell mass for Cdk4WT and Cdk4R/R pancreas, respectively (Fig. 4). Next, we estimated the ICC contributions that represent islet neogenesis from ducts. Assuming that 500 sections can be obtained from a pancreas and single cell mass can be estimated from water density (~1.8×10−6 mg/cell), increasing numbers of ICCs correspond to 0.09 mg for Cdk4WT and 0.23 mg for Cdk4R/R pancreas. In spite of a large variation of β-cell mass changes, contributions from β-cell replication and ICCs (defined cell clusters including below 5 cells) are not sufficient to explain the β-cell mass increase during 14 days after pancreatectomy. Proliferation was assayed by two methods: (i) BrdU incorporation by intra-peritoneal injection, and (ii) by administration of CIdU and IdU via drinking water. Kushner's laboratory has shown that CldU/IdU labeling is as efficient as BrdU labeling at detecting β-cell proliferation , thus we believe that our results accurately reflect the numbers of proliferating cells in the Cdk4 models. However, it is possible that the BrDU and CIdU/IdU labeling indices may be under-estimated in our analyses although it is unlikely that would explain such a large gap in β-cell mass increase. Taken together, we suggest the possibility of non-proliferative contribution to the β-cell mass increase. For example, β-cell hypertrophy may be partially responsible for the observed β-cell mass increase. Further, mechanisms that involve compensatory de-differentiation could account for increase to β-cell mass. Indeed, Collombat and colleagues recently illustrated a mechanism of expansion of the β-cell mass in response to injury wherein pancreatic progenitor cells are capable of giving rise to glucagon-expressing α-cells that then transdifferentiate into β-cells , . Importantly, it was shown that the continuous neogenesis of β-cells through the cell re-differentiation program did not involve β-cell self-renewal . The possible existence of a large non-proliferative source of β-cells is surprising given the knowledge of replication-competent β-cells that drive regeneration of β-cell mass , , . We do observe substantial numbers of proliferating cells in response to pancreatectomy and indeed Cdk4R24C seems to promote the proliferation process. However, in addition we find a hitherto uncharacterized large non-proliferative pool of cells that Cdk4 can coax to participate in the regenerative response. It should be noted that distinct populations of quiescent and proliferative β-cells have been identified in another model organism recently .
Prior to the restriction point, cells can temporarily exit the cell cycle and undergo quiescence – a distinct out-of-cycle state that is under active genetic control (Fig. 7A). Previously, we and others have shown that loss of Cdk4 results in delayed S-phase entry from quiescence and a prolonged S phase , . Here, we showed that Cdk4R24C promoted β-cell proliferation within islets via a process of self-duplication. In addition, the mathematical model suggested that Cdk4R24C may recruit quiescent cells in islets to re-enter the cell cycle. The most dramatic effect of Cdk4R24C appears to be in the pancreatic ductal epithelium where we observed rapid proliferation activity and strong activation of the early developmental marker Pdx-1 within 24–48 hours after pancreatectomy. The appearance of Pdx-1+ cells in the regenerating ductal epithelium of the Cdk4R/R pancreas is suggestive of progenitor/stem cell activation in response to pancreatectomy and lineage tracing analyses will offer conclusive evidence in this regard. It has been postulated that the size of the pancreas is fixed during development due to the limited number of progenitor cells . Our findings suggest that such presumptive progenitors may be responsive to context-dependent activation, such as injury. Similar activation of endocrine pancreatic progenitor cells, expressing the endocrine marker neurogenin 3 (Ngn3), has been reported in response to duct-ligation . We did not observe Ngn3+ cells in our study before or after pancreatectomy. It is plausible that the two types of injuries, pancreatectomy versus duct-ligation, may foster activation of distinct progenitor cell populations that express either Pdx1 or Ngn3. Moreover, it is likely that the 60% pancreatectomy may be a relatively mild injury compared with the duct-ligation technique that may elicit a distinct genetic and physiological response. Alternatively, the kinetics of regeneration and the time-period of appearance of Ngn3+ cells in response to the two types of injuries are distinct enough to preclude detection of Ngn3+ cells in our model. Additionally, post-transcriptional regulation of Ngn3 within the regenerating pancreas may preclude observation of Ngn3 positive cells as described elsewhere .
In summary, our findings suggest that the Cdk4-p16Ink4a pathway regulates the long-term quiescent state of β-cells within islets and of potential progenitors within the pancreatic ductal epithelium (Fig. 7). Thus, reduced Cdk4 activity, due to an intact p16Ink4a checkpoint, promotes an extended quiescent state, a property exhibited by a majority of β-cells. Activation of Cdk4, instead, overcomes the p16Ink4a enforced quiescence and promotes re-entry of cells into the cell cycle. In addition, loss of the p16Ink4a checkpoint may preclude already cycling cells from exiting the cell cycle into a quiescent state. Recruitment of quiescent cells to re-enter the cell cycle and promotion of cells within the cell cycle to continue dividing are central Cdk4-regulated mechanisms that control reconstitution of β-cell mass.
Generation of Mice
All experiments used age-matched (6–8 weeks old) female and male mice. All mice were housed in the animal facility at National Institutes of Health (NIH) in accordance with NIH regulations under specific pathogen-free conditions. All animal work is in accordance with the protocols approved by the NIH Animal Use and Care Committee.
The entire splenic portion of the pancreas was surgically removed, resulting in a ~60% pancreatectomy. Sham operation was performed as control for the multiple thymidine analog labeling experiment. Blood glucose level was determined by using an AscensiaELITE glucometer (Bayer Co., IN) before and after pancreatectomy.
Mice were given an intraperitoneal injection of 100 mg/Kg B.W. BrdU (Sigma, St. Louis, MO) 16 hr before sacrifice.
Multiple Thymidine Analog Labeling
After partial pancreatectomy was performed, mice were continuously administered 5-chloro-2-deoxyuridine (CldU) or 5-iodo-2-deoxyuridine (IdU) in drinking water at 1 mg/ml for different time periods according to labeling scheme. CldU and BrdU were obtained from Sigma-Aldrich (St. Louis, Mo) and IdU was purchased from MP Biomedicals (Santa Ana, CA). During the chase period, the mice were given regular drinking water.
Pancreatic tissue samples were harvested and fixed in 10% formalin solution. Paraffin-embedded sections (5 µm) were used in immunohistochemistry analyses. Sections were immunostained with guinea pig anti-insulin (Dako, Carpinteria, CA), mouse anti-pan cytokeratin (Dako, Carpinteria, CA), mouse anti-BrdU (Dako, Carpinteria, CA) or rabbit anti-Pdx-1 (Chemicon, Billerica, MA). For multiple thymidine analog labeling study, the staining procedure was according to the protocol published by Teta M. et al. (29). In brief, sections were first rehydrated, then microwaved in 0.01 M sodium citrate buffer, followed by permeabilization with 0.2% Triton X-100, incubation in 1.5 N HCL, and treatment with 0.25% trypsin (Invitrogen, Carlsbad, CA). Sections were then incubated to detect CldU using a rat anti-BrdU antisera (BU1/75; Accurate Chemical, Westbury, NY). IdU was detected using a mouse anti-BrdU antisera (BD Biosciences, Franklin Lakes, NJ). Guinea pig anti-insulin (Zymed Laboratories Inc., South San Francisco, CA) was used followed by incubation with secondary antisera conjugated to Cy2, Cy3 or Cy5 (Jackson ImmunoResearch Laboratories, West Grove, PA).
Measurement of β-Cell Mass
For each pancreas, at least 3 inconsecutive sections with 150 µm separation were randomly chosen for staining. Sections were immunostained for insulin using a peroxidase indirect labeling technique. Quantitative evaluation of total β-cell mass was performed using image analysis software (Metamorph, CA). The areas of insulin-positive cells, as well as that of total pancreatic sections, were evaluated for each stained section. The relative volume of β-cells was determined by the stereological morphometry method, calculating the ratio between the area occupied by immunoreactive cells and that occupied by the total pancreatic tissue. Total β-cell mass per pancreas was derived by multiplying this ratio by the total pancreatic weight. Results represent the average from 4 animals per group.
Stained pancreatic sections showed either insulin-positive β-cells or cytokeratin positive ductal cells together with BrdU-positive staining. At least 1000 β-cell nuclei or CK-positive ductal cells were counted per animal and at least 5 animals per group were subject to such analyses. The proportion of BrdU-positive β-cells (or BrdU-positive ductal cells) to total number of β-cells (or total number of ductal cells) was quantified. The result represents the percentage of proliferating rate in either β-cells or ductal cells.
Islet-Like Cell Clusters (ICCs)
The number of islet-like cell clusters that comprise five or less β-cells was counted subsequent to insulin immunohistochemistry.
We developed a mathematical model to examine the characteristics of cell proliferation from the labeling results of CldU+, IdU+, and CldU+:IdU+ cells (Fig. 3A). To distinguish the different potential for cell proliferation, we separated cell populations into quiescent and active cells. We denote the number of quiescent cells with and the number of active cells with . Quiescent cells do not proliferate:
On the other hand, active cells proliferate with a given time-dependent proliferation rate . When active cells proliferate, mother and daughter cells become labeled with thymidine analogs in newly-synthesized DNA after mitosis. Note that we assumed symmetric DNA segregation. Therefore, a proliferated active cell becomes two labeled cells:
Here, we neglect multiple proliferations of once-proliferated cells because the event is sufficiently rare (Table S1). The rate of cell proliferation may begin to increase by the PX stimulation, and diminish after a certain time point. Therefore, we use the following functional form multiplying two sigmoidal functions for rising and falling phases:where is the magnitude of the proliferation rate; and represent the time points for rising and falling phases at which the proliferation rate has the half maximal value of ; finally, and give the time scales for the slopes of the rising and falling phases, respectively. The functional form is general enough to describe even monotonically-increasing proliferation rate during a measuring period, if is larger than the given period. We apply this basic model to examine cell proliferation. For a time period from an initial time to a final time , the ratio of labeled cells to unlabeled cells is
For example, in the 2-2-4 labeling protocol, the CldU+ labeling ratio becomes ; and the IdU+ labeling ratio becomes . In case of single labeling with BrdU, the labeling ratio from day 1 to day 2 becomes . Note that we use for calculating basal labeling ratio per day.
We have two kinds of cell proliferation information. First, single labeling with BrdU represents cell proliferation at day 0, 1, 2, and 14. Second, double labeling with CldU and IdU represents accumulated cell proliferation for a given period that depends on the experimental protocols: 2-2-4, 2-2-14, and 7-7-14 (Fig. 3B). Therefore, we have totally ten sets of independent labeling data (four with BrdU, three with CldU, and three with IdU): with = 1, 2, …, 10 for each ensemble of = 1, 2, …, . Using the mathematical model, we examine characteristics of cell proliferation which can appropriately explain the results of both experiments. In the labeling results, scale of labeling ratio is not comparable between BrdU and CldU/IdU labeling; BrdU could detect more proliferated cells. The difference may result from the injection method difference (intraperitoneal injection of BrdU vs. by drinking water that includes CldU/IdU). It is also possible that we observed CldU/IdU-labeled cells in lower laser intensity and less laser-exposure time. Therefore, we introduce a scale parameter η to scale up CldU/IdU labeling results; for = 1, …, 4 and for = 5, …, 10. To compare these with model predictions , we define a cost function, quantifying the deviation between them,where we consider the experimental uncertainty as a weight; as the error is smaller, we weight the corresponding data as more significant. The uncertainty is the standard deviation of data for the th labeling ratio:with the mean value .
Then, we simulate the model with the parallel tempering Monte-Carlo (MC) method (60) for sampling in the seven-dimensional parameter space, , and find the best parameter minimizing the cost . To obtain the global minimum of the cost function, the MC method simultaneously runs several chains with different temperatures (fluctuations). It allows both coarse and fine search for the best parameter set. In particular, we used ten temperatures from to with a uniform spacing interval of 0.1. The updating probability of the MC simulation is for the th chain. In addition, after every 20 time-steps, we randomly picked two chains of different temperatures ( and ) and exchanged their parameter set ( and ) with the probability to find the global minimum of the cost function more efficiently. After finding the best parameter set, we ran MC steps with one fixed temperature () from the best parameter set found in the equilibration. From the random walk of around , we can estimate the average and the standard deviation of optimal parameter values. At first, we found the most probable values of the scale parameter η (2.4±0.9 and 2.3±0.8 for of β-cells in Cdk4WT and Cdk4R/R mice, respectively; 2.2±0.9 and 3.7±0.2 for of ductal cells in Cdk4WT and Cdk4R/R mice, respectively). Therefore, as a universal scale parameter that should consistently apply all the CldU/IdU labeling experiment, we fixed the scale parameter with η = 3; then, we treated η as a constant, not a parameter. For the model comparison, we used the Bayesian model probability that estimates how a model can describe a given data well . The probability can be calculated from the MC simulation with different temperatures: for using 10 chanis, . Here, means the average cost for each temperature . Note that for this calculation, there is no exchange between MC chains of different temperatures in contrast to the previous procedure for searching a global minimum of a cost function. In addition, we used MC steps to determine the model probability .
All results are reported as means ± SE. Statistical analysis was performed by independent t-test (unpaired and two-tailed).
(2.90 MB TIF)
(6.84 MB TIF)
Model probabilities of population ratio of quiescent to active cells for β-cells and ductal epithelial cells of Cdk4WT and Cdk4R/R mice.
(0.86 MB TIF)
(0.05 MB DOC)
The authors would like to thank Jake Kushner for his advice on the double-thymidine labeling assays; Artie Sherman and David M. Harlan for critical reading of the manuscript; and the Rane laboratory members for discussion.
Conceived and designed the experiments: JJ VP SGR. Performed the experiments: JHL AAH. Analyzed the data: JHL JJ VP SGR. Contributed reagents/materials/analysis tools: AAH. Wrote the paper: JJ VP SGR.
- 1. Hellerstrom C (1984) The life story of the pancreatic B cell. Diabetologia 26: 393–400.
- 2. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840–846.
- 3. Muoio DM, Newgard CB (2008) Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9: 193–205.
- 4. Weir GC, Bonner-Weir S (2004) Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53: Suppl 3S16–21.
- 5. Hellerstrom C, Swenne I (1991) Functional maturation and proliferation of fetal pancreatic beta-cells. Diabetes 40: Suppl 289–93.
- 6. Swenne I, Andersson A (1984) Effect of genetic background on the capacity for islet cell replication in mice. Diabetologia 27: 464–467.
- 7. Butler PC, Meier JJ, Butler AE, Bhushan A (2007) The replication of beta cells in normal physiology, in disease and for therapy. Nat Clin Pract Endocrinol Metab 3: 758–768.
- 8. Swenne I (1983) Effects of aging on the regenerative capacity of the pancreatic B-cell of the rat. Diabetes 32: 14–19.
- 9. Teta M, Long SY, Wartschow LM, Rankin MM, Kushner JA (2005) Very slow turnover of beta-cells in aged adult mice. Diabetes 54: 2557–2567.
- 10. Heit JJ, Karnik SK, Kim SK (2006) Intrinsic regulators of pancreatic beta-cell proliferation. Annu Rev Cell Dev Biol 22: 311–338.
- 11. Bonner-Weir S, Sharma A (2002) Pancreatic stem cells. J Pathol 197: 519–526.
- 12. Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE (1993) A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 42: 1715–1720.
- 13. Zulewski H, Abraham EJ, Gerlach MJ, Daniel PB, Moritz W, et al. (2001) Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 50: 521–533.
- 14. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, et al. (2001) Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292: 1389–1394.
- 15. Ianus A, Holz GG, Theise ND, Hussain MA (2003) In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 111: 843–850.
- 16. Hess D, Li L, Martin M, Sakano S, Hill D, et al. (2003) Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 21: 763–770.
- 17. Lipsett M, Finegood DT (2002) beta-cell neogenesis during prolonged hyperglycemia in rats. Diabetes 51: 1834–1841.
- 18. Gershengorn MC, Hardikar AA, Wei C, Geras-Raaka E, Marcus-Samuels B, et al. (2004) Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science 306: 2261–2264.
- 19. Guz Y, Nasir I, Teitelman G (2001) Regeneration of pancreatic beta cells from intra-islet precursor cells in an experimental model of diabetes. Endocrinology 142: 4956–4968.
- 20. Kodama S, Kuhtreiber W, Fujimura S, Dale EA, Faustman DL (2003) Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 302: 1223–1227.
- 21. Ferber S, Halkin A, Cohen H, Ber I, Einav Y, et al. (2000) Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 6: 568–572.
- 22. Sapir T, Shternhall K, Meivar-Levy I, Blumenfeld T, Cohen H, et al. (2005) Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells. Proc Natl Acad Sci U S A 102: 7964–7969.
- 23. Shen CN, Slack JM, Tosh D (2000) Molecular basis of transdifferentiation of pancreas to liver. Nat Cell Biol 2: 879–887.
- 24. Chong AS, Shen J, Tao J, Yin D, Kuznetsov A, et al. (2006) Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration. Science 311: 1774–1775.
- 25. Desai BM, Oliver-Krasinski J, De Leon DD, Farzad C, Hong N, et al. (2007) Preexisting pancreatic acinar cells contribute to acinar cell, but not islet beta cell, regeneration. J Clin Invest 117: 971–977.
- 26. Nishio J, Gaglia JL, Turvey SE, Campbell C, Benoist C, et al. (2006) Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution. Science 311: 1775–1778.
- 27. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA (2008) In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455: 627–632.
- 28. Dor Y, Brown J, Martinez OI, Melton DA (2004) Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429: 41–46.
- 29. Georgia S, Bhushan A (2004) Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest 114: 963–968.
- 30. Teta M, Rankin MM, Long SY, Stein GM, Kushner JA (2007) Growth and regeneration of adult beta cells does not involve specialized progenitors. Dev Cell 12: 817–826.
- 31. Xu X, D'Hoker J, Stange G, Bonne S, De Leu N, et al. (2008) Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 132: 197–207.
- 32. Malumbres M, Barbacid M (2005) Mammalian cyclin-dependent kinases. Trends Biochem Sci 30: 630–641.
- 33. Rane SG, Reddy EP (2000) Cell cycle control of pancreatic beta cell proliferation. Front Biosci 5: D1–19.
- 34. Mettus RV, Rane SG (2003) Characterization of the abnormal pancreatic development, reduced growth and infertility in Cdk4 mutant mice. Oncogene 22: 8413–8421.
- 35. Rane SG, Cosenza SC, Mettus RV, Reddy EP (2002) Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence. Mol Cell Biol 22: 644–656.
- 36. Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, et al. (1999) Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet 22: 44–52.
- 37. Cozar-Castellano I, Fiaschi-Taesch N, Bigatel TA, Takane KK, Garcia-Ocana A, et al. (2006) Molecular control of cell cycle progression in the pancreatic beta-cell. Endocr Rev 27: 356–370.
- 38. Georgia S, Bhushan A (2006) p27 Regulates the transition of beta-cells from quiescence to proliferation. Diabetes 55: 2950–2956.
- 39. Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, et al. (2006) p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443: 453–457.
- 40. Kushner JA, Ciemerych MA, Sicinska E, Wartschow LM, Teta M, et al. (2005) Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol Cell Biol 25: 3752–3762.
- 41. Rachdi L, Balcazar N, Elghazi L, Barker DJ, Krits I, et al. (2006) Differential effects of p27 in regulation of beta-cell mass during development, neonatal period, and adult life. Diabetes 55: 3520–3528.
- 42. Uchida T, Nakamura T, Hashimoto N, Matsuda T, Kotani K, et al. (2005) Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat Med 11: 175–182.
- 43. Zhang X, Gaspard JP, Mizukami Y, Li J, Graeme-Cook F, et al. (2005) Overexpression of cyclin D1 in pancreatic beta-cells in vivo results in islet hyperplasia without hypoglycemia. Diabetes 54: 712–719.
- 44. Marzo N, Ortega S, Stratmann T, Garcia A, Rios M, et al. (2008) Cyclin-dependent kinase 4 hyperactivity promotes autoreactivity in the immune system but protects pancreatic cell mass from autoimmune destruction in the nonobese diabetic mouse model. J Immunol 180: 1189–1198.
- 45. Bonner-Weir S, Toschi E, Inada A, Reitz P, Fonseca SY, et al. (2004) The pancreatic ductal epithelium serves as a potential pool of progenitor cells. Pediatr Diabetes 5: Suppl 216–22.
- 46. Inada A, Nienaber C, Katsuta H, Fujitani Y, Levine J, et al. (2008) Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc Natl Acad Sci U S A 105: 19915–19919.
- 47. Sharma A, Zangen DH, Reitz P, Taneja M, Lissauer ME, et al. (1999) The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes 48: 507–513.
- 48. Waguri M, Yamamoto K, Miyagawa JI, Tochino Y, Yamamori K, et al. (1997) Demonstration of two different processes of beta-cell regeneration in a new diabetic mouse model induced by selective perfusion of alloxan. Diabetes 46: 1281–1290.
- 49. Peshavaria M, Larmie BL, Lausier J, Satish B, Habibovic A, et al. (2006) Regulation of pancreatic beta-cell regeneration in the normoglycemic 60% partial-pancreatectomy mouse. Diabetes 55: 3289–3298.
- 50. Liu YQ, Nevin PW, Leahy JL (2000) beta-cell adaptation in 60% pancreatectomy rats that preserves normoinsulinemia and normoglycemia. Am J Physiol Endocrinol Metab 279: E68–73.
- 51. Edlund H (2002) Pancreatic organogenesis–developmental mechanisms and implications for therapy. Nat Rev Genet 3: 524–532.
- 52. Offield MF, Jetton TL, Labosky PA, Ray M, Stein RW, et al. (1996) PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122: 983–995.
- 53. Tsutsui T, Hesabi B, Moons DS, Pandolfi PP, Hansel KS, et al. (1999) Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity. Mol Cell Biol 19: 7011–7019.
- 54. Collombat P, Xu X, Ravassard P, Sosa-Pineda B, Dussaud S, et al. (2009) The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells. Cell 138: 449–462.
- 55. Liu Z, Habener JF (2009) Alpha cells beget beta cells. Cell 138: 424–426.
- 56. Hesselson D, Anderson RM, Beinat M, Stainier DY (2009) Distinct populations of quiescent and proliferative pancreatic beta-cells identified by HOTcre mediated labeling. Proc Natl Acad Sci U S A 106: 14896–14901.
- 57. Stanger BZ, Tanaka AJ, Melton DA (2007) Organ size is limited by the number of embryonic progenitor cells in the pancreas but not the liver. Nature 445: 886–891.
- 58. Joglekar MV, Parekh VS, Mehta S, Bhonde RR, Hardikar AA (2007) MicroRNA profiling of developing and regenerating pancreas reveal post-transcriptional regulation of neurogenin3. Dev Biol 311: 603–612.
- 59. Gregory PC (2005) Bayesian logical data analysis for the physical sciences: a comparative approach with mathematica support. Cambridge, UK: Cambridge Universigy Press.